Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 40Terminated 6Unknown 5Active not recruiting 4Recruiting 2Withdrawn 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Polycystic Ovary Syndrome 2

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × Flutamide × Clear all
NCT00930228 2023-11-02

CRM004

University of Virginia

Phase 1 Unknown
72 enrolled

Polycystic Ovary Syndrome

NCT04597099 2023-11-02

CRM010

University of Virginia

Phase EARLY_PHASE1 Unknown
10 enrolled

Polycystic Ovary Syndrome

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Wonju Severance Christian Hospital

Phase 4 Unknown
164 enrolled
Genitourinary

Prostatic Neoplasms

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Fudan University

Phase 2 Unknown
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
276 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡